This article provides an overview of the prevalence of e-cigarette use among youths aged 12 to 16 across 68 countries and territories, based on data from 2012 to 2019.
It highlights key factors associated with e-cigarette use among adolescents and discusses implications for public health and policy interventions.
This page provides an explainer summary based on the available research paper information. It is not a copy of the original paper. For complete methodology, data, findings, and full text, please visit the original source.
View Original SourceUnderstanding the prevalence and factors associated with youth e-cigarette use is crucial for developing effective public health interventions to prevent nicotine addiction among adolescents.
This knowledge helps policymakers and health professionals address emerging trends and protect youth health globally.
This study underscores the importance of monitoring e-cigarette use among youths to inform public health strategies aimed at reducing tobacco-related harms in this vulnerable population.
Addressing e-cigarette use can help prevent long-term health consequences associated with nicotine addiction and tobacco use.
The findings support the need for robust policies to regulate e-cigarette marketing, sales, and use among minors, ensuring effective prevention and control measures are in place.
Policymakers can leverage this data to strengthen existing tobacco control laws and implement targeted youth prevention programs.
یہ رپورٹ دنیا بھر میں 12 سے 16 سال کے نوجوانوں میں ای-سگریٹ کے استعمال کی شرح اور اس سے منسلک عوامل کا جائزہ لیتی ہے۔
یہ معلومات صحت کے حکام اور پالیسی سازوں کے لیے اہم ہیں تاکہ نوجوانوں میں سگریٹ نوشی کے خلاف مؤثر اقدامات کیے جا سکیں۔
Choose how you want to understand this article. The AI can explain it in simple language, Urdu, bullet points, Q&A, policy brief, or research-style notes using the available explainer content and original source link where possible.
This feature is powered by AI and is intended to help readers better understand research papers, reports, articles, and public-health information. AI-generated responses may occasionally be incomplete or limited. This feature does not replace the original source, medical advice, professional research review, or official policy guidance. For complete methodology, data, findings, and full text, please refer to the original source.